Experienced in Gaucher Disease

Wei J. Zhong

Peking Union Medical College Hospital, Peking Union Medical College, 
Beijing, CN 
Experienced in Gaucher Disease
Peking Union Medical College Hospital, Peking Union Medical College, 
Beijing, CN 
OverviewLocationsClinical Research

Overview

Wei Zhong practices in Beijing, China. Zhong is rated as an Experienced expert by MediFind in the treatment of Gaucher Disease. Their top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Hemangiopericytoma.

Their clinical research consists of co-authoring 386 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Gaucher Disease.

Locations

Peking Union Medical College Hospital, Peking Union Medical College, Beijing, China
Other Locations
Jiefang Road 438, Zhenjiang, 212013, China
#98 West Nantong Rd, Yangzhou, China
3663# North Zhongshan Road, Zhongshan, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase II Single-arm Study of Sintilimab After Thoracic Radiation in Previously Treated Advanced NSCLC
A Phase II Single-arm Study of Sintilimab After Thoracic Radiation in Previously Treated Advanced NSCLC
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Sintilimab
Study Phase: Phase 2

386 Total Publications

Alectinib versus crizotinib as the first-line treatment in patients with advanced ALK-positive non-small cell lung cancer: a Chinese real-world cohort study.
Alectinib versus crizotinib as the first-line treatment in patients with advanced ALK-positive non-small cell lung cancer: a Chinese real-world cohort study.
Journal: Translational lung cancer research
Published: September 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhong's expertise for a condition
ConditionClose
    View All 45 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile